Drug Profile
Influenza virus vaccine intranasal
Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Hadassah Medical School
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 12 Jan 2004 No development reported - Clinical-Phase-Unknown for Influenza virus infections in Israel (Intranasal)
- 11 Jan 2000 A study in elderly volunteers has been added to the Viral Infections immunogenicity section
- 12 Oct 1999 A study has been added to the adverse events section and the Viral Infections immunogenicity section